To Top

Search By Topic

Outsourcing

125 Articles available
Biologics

Biologics: Driving Force in Pharma

PAP-Q2-17-NO-001
Biologics

Hiring Top Talent in Pharma

Robert Hoyle, President, Global Talent Solutions

PTV-M11-16-AP-009
Outsourcing

Analytical Testing Outsourcing Trends Update

CPP-M03-17-NI-001
API

Changes in the Wind for the CDMO Market

PAP-Q1-17-FA-002
Outsourcing

Spending on Contract Research Services Slowing Down

PAP-Q1-17-FA-003
Outsourcing

Growth Anticipated for Intermediates

PAP-Q1-17-FA-005
CDMO

Operational Excellence in Outsourced Fill-Finish Services

PAP-Q1-17-IC-001
CDMO

Flexible Partnership, Inflexible Quality

PAP-Q1-17-CL-016
CDMO

Facilitating Tech Transfer for Parenteral Products

PAP-Q1-17-CL-010
API

Supporting the Pharma Industry Small Business Growth Engine

PAP-Q1-17-CL-017
Outsourcing

Integrated Innovation: Fostering the New Growth in Pharma

PAP-Q1-17-CL-003
CDMO

Raw Material Supply: Many Issues to Manage

POP-M10-16-NI-001
Outsourcing

2016 CRO Industry Leaders

PAP-Q1-16-IL-002
CDMO

2016 CDMO Industry Leaders

PAP-Q02-16-IL-001
Outsourcing

Expanding Trial Data Demands New Analytical Methods

MCP-M09-16-NI-001
Biologics

INNOVATION: Creating Solutions for Healthcare’s Ambitious Agenda

PAP-Q04-16-FA-001
API

A New Industry Think Tank Forum for Leaders of Outsourced Services and Customers

PAP-Q04-16-NS-001
CDMO

This Just In

PAP-Q04-16-JI-001
API

Cultivating a Proactive Quality Culture

PAP-Q04-16-CL-008
CDMO

Nice Insight Launches 2017 Study Season

PAP-Q04-16-NI-001
CDMO

Transforming the Pharmaceutical Industry Pipeline with In Silico Approaches

PAP-Q04-16-CL-011
CDMO

Seeking Quality Deals: Consolidation and Acquisition

PAP-Q04-16-VP-002
Outsourcing

Shaping the Conversation – Bringing Voice & Value

PAP-Q04-16-ED-001
API

Targeted, Highly Potent Therapies: Big Growth Driver for the CDMO Market is Here...

SCP-M09-16-NI-001
CDMO

Pharma’s Role in Pediatric Medication Adherence

PMP-M08-16-NI-001
CDMO

Collaboration is the Name of the Game

PAP-Q03-16-IN-001
Excipients

Quality by Design: Transforming 21st Century Pharmaceutical Manufacturing

PAP-Q03-16-CL-003
CDMO

Pharma’s Renaissance Continues

PAP-Q03-16-ED-001
API

Joint Venture Contract Services – A CDMO’s Approach to Being a True Partner

PAP-Q03-16-CL-016
CDMO

Evolving Strategic Partnership Models

PAP-Q03-16-CL-007
Patient Adherence

Function and Form: Advanced Pharma Packaging Design and Processing

PAP-Q03-16-CL-014
CDMO

Sustainable Strategies for Contract Development and Manfacturing Service Growth

PAP-Q03-16-NC-001
API

Creating a Global C‘R’DMO for the Future of (Bio)pharma: Effective Strategies and Tactics

PAP-Q03-16-CL-001
CDMO

Effective Quality Assurance Capabilities Essential for CDMO/CRO Success

MCP-M07-16-NI-001
Supply Chain

Strong Growth for CRO Market; Tox Testing Poses Challenges

SCP-M07-16-NI-001
Equipment

Pharma Equipment Budget Expansion Fueling Quest For Operational Excellence

APR-M06-16-NI-001
CDMO

Sponsor Company Size Influences Contract Service Provision

POP-M05-16-NI-001
CDMO

Increasing the Chances of Finding the Best Possible CRO/CMO Fit

MCP-M05-16-NI-001
Outsourcing

Ways to Lower Costs of Clinical Trials and How CROs Help

APR-M04-16-NI-001
CDMO

Single-Use Equipment Proving Useful Managing Biomanufacturing Costs

PAP-Q02-16-NI-002
CDMO

Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals

PAP-Q02-16-CL-011
API

Expect Pharmaceutical Contract Manufacturing to Continue Apace in 2016

POP-M03-16-NI-001
CDMO

Nice Insight Outsourcing Trends in 2016

APR-M03-16-NI-001
API

Look for More Outsourcing of Research Activities in 2016

APR-M01-16-NI-002
Outsourcing

Another Exciting Year for Clinical Research Outsourcing

PAP-Q1-16-FA-002
CDMO

Advancing Biologics Development and Manufacturing

PAP-Q1-16-CL-011
Biologics

The Buzz Around Oncology — Update On Biologics Approvals

LSL-M11-15-NI-001
Biologics

Be Innovative! Maneuvering the Global Pharmaceutical Market

PAP-Q4-15-NO-001
CDMO

A Look At 2015 Outsourcing Trends And What To Expect In 2016

LSL-M10-15-NI-001
Biopharmaceuticals

Manufacturers and CMOs Streamline Bioprocessing with Single-Use Devices

POP-M09-15-NI-001
Outsourcing

Advanced Technologies Cited as Essential for Clinical Trial Challenges

LSL-M09-15-NI-001
Outsourcing

Nice Insight Survey: Focus on Automated Laboratory Systems

POP-M07-15-NI-001
Outsourcing

Outsourcing Increasing To CROs And CMOs Known For Quality And Cost-Effectiveness

LSL-M07-15-NI-001
Outsourcing

CRO or CMO: Which Is Best For Your Preformulation Needs?

LSL-M05-15-NI-001
Outsourcing

Leads Ways of selecting CMOs and CROs

MCP-M04-15-NI-001
CDMO

Four Keys to Successful Biopharmaceutical Outsourcing: Technical Expertise, Quality, Reliability and Timeliness

PAP-APR-S01-CL-001
Patient Adherence

Why Innovative Drug Delivery Packaging Solutions Are Needed for Today’s Patients

PAP-APR-S01-CL-003
Outsourcing

Biopharmaceutical Outsourcing To CROs In Emerging Markets Surges For 2015

LSL-M03-15-NI-002
Outsourcing

Selecting An Outsourcing Partner For Vaccine Production

ICO-M03-15-NI-001
CDMO

What Does 2015 Hold For The Indian CMO Industry?

LSL-M03-15-NI-003
Outsourcing

Industry Data: Developing Targeted Marketing Strategies

MCP-M02-15-NI-001
Biologics

Bioreactor Preferences from an Outsourcing Perspective – Part I

PMP-M02-15-NI-001
Outsourcing

Identifying Segmentation Within the Pharmaceutical Outsourcing Market

POP-M02-15-NI-001
CDMO

The CDMO Model And Outsourcing Development

LSL-M02-15-NI-001
Outsourcing

Innovation Moves Up in Rank and Technologies Move into the Outsourcing Paradigm

LSL-M01-15-NI-001
Outsourcing

A Recap on 2014 Outsourcing Trends and What to Expect in 2015

LSL-M12-14-NI-001
Outsourcing

Is Discounting Services Good for Drug Development?

LSL-M10-14-NI-001
Outsourcing

The Continued Evolution of the Sponsor-CRO Relationship

LSL-M08-14-NI-001
Outsourcing

Emerging Pharma and Emerging Biotech Value Different Traits in CROs

LSL-M08-14-NI-002
Biologics

Outsourcing Biomanufacturing Continues to Grow in Frequency

LSL-M07-14-NI-003
Outsourcing

An Update on the Buzz Around Oncology

LSL-M07-14-NI-002
API

Outsourcing Trends in Small Molecule API Manufacturing

LSL-M07-14-NI-001
Outsourcing

Sponsors Not the Only Party to Benefit from Clinical Trials in Emerging Markets

POP-M06-14-NI-001
Biologics

Pre-filled Syringe Technology Benefits Patients, Healthcare Providers and Drug Makers

CIO-M06-14-NI-001
Supply Chain

As Outsourcing Relationships Evolve, Vaccine Production Will Continue to Shift to CMOs

LSL-M05-14-NI-002
Outsourcing

Can CROs Help Reduce the Expense of Clinical Trials?

LSL-M05-14-NI-001
CDMO

Increased Demand for Vaccines will Continue to Benefit CMOs

CIO-M04-14-NI-001
API

Trends in Outsourcing Solid Dose Manufacturing in 2014

LSL-M03-14-NI-002
Biologics

Outsourcing To CROs And CMOs In Emerging Markets In 2014

CIO-M01-14-NI-002
Outsourcing

What Can 2013 Outsourcing Trends Lead Us to Expect In 2014

LSL-M12-13-NI-001
Biologics

Outsourcing Biomanufacturing

CIO-M09-13-NI-001
Outsourcing

The Top CROs by Therapeutic Indication Share Strong Regulatory and Productivity Performance

LSL-M09-13-NI-001
Biologics

CROs and CMOs Continuing Drug Delivery Innovation

CIO-M08-13-NI-001
Outsourcing

Trends In Outsourcing — What’s Going On In Big Pharma

LSL-M06-13-NI-001
API

Competition Yields Benefits for Pharma Companies Outsourcing API Manufacturing

CIO-M05-13-NI-001
Outsourcing

Quality and Reliability Will Continue to Drive Outsourcing Relationships in 2013

CIO-M04-13-NI-001
Outsourcing

Outsourcing Clinical Research — Trends by Customer Group

LSL-M03-13-NI-001
Outsourcing

The Evolving Dynamic Of The Sponsor-CRO Relationship

CIO-M12-12-NI-001
Outsourcing

How Relevant are 483s in Terms of Compliance Perception?

CIO-M11-12-NI-001
Outsourcing

Strategic Partnering for Innovation

CIO-M10-12-NI-001
Outsourcing

Evolution in the Research Used for the CMO Awards

LSL-M10-12-NI-001
Outsourcing

A Diversified Portfolio of Contract Providers Might Improve Results

LSL-M03-13-NI-002
Outsourcing

The Right Preformulation / Formulation Outsourcing Partner Can Alleviate Challenges To Reducing Costs

CIO-M09-12-NI-001
Outsourcing

Capacity Issues and the Question: To Insource or Outsource?

LSL-M08-12-NI-001
Outsourcing

CROs & CMOs: Focusing On Innovation

LSL-M05-12-NI-001
Outsourcing

Advancing Sponsor/CRO Collaborations to Improve Preclinical Throughput

LSL-M05-12-NI-002
Outsourcing

Outsourcing Clinical Research: Established vs. Emerging Markets

PPO-M05-12-NI-001
Outsourcing

Key Drivers for Outsourcing Partner Selection

LSL-M02-12-NI-001
Outsourcing

Outsourcing to Emerging Markets: The Effect of the European Economic Crisis

PTO-M02-12-NI-001
Outsourcing

Best Practices for Targeted Marketing Communications

DDD-M01-12-NI-001
Outsourcing

Optimizing the Partner Selection Process for Drug Developers

LSL-M12-11-NI-002
Outsourcing

Who Should Be Doing Your Pharmaceutical Analytical Testing — a CRO or CMO?

PPO-M12-11-NI-001
Supply Chain

Is a CMO With a Global Supply Chain Always the Best Option?

LSL-M11-11-NI-001
Outsourcing

What CROs and CMOs Can Learn from Q3 Outsourcing Data and 2011 Trends

PQO-M11-11-NI-001
Outsourcing

Tools That Improve Outsourcing Selection

PPO-M11-11-NI-001
Outsourcing

Connecting CMOs and CROs and Big Pharma

PPO-M09-11-NI-001
CDMO

Customer Drivers Influencing Supplier Differentiation

PTO-M08-11-NI-001
Outsourcing

Do Companies That Offer Regulatory Support Services Score Higher On Regulatory Compliance?

LSL-M08-11-NI-001
Outsourcing

Nice Insight Announces Publication Of Its Q2 CRO/CMO Quarterly Intelligence Report

ACT-M06-11-NI-001
Outsourcing

The Conversation That Got Me Thinking Of A New Business Concept

Outsourcing

Outsourcing Insights

LSL-M05-11-NI-001
API

Bringing Order To The Outsourced Manufacturing Space

PC0-M04-11-NI-001
//Fix for text overflow in cards